BEGIN:VCALENDAR

VERSION:2.0

PRODID:-//wp-events-plugin.com//7.2.2.1//EN

TZID:Asia/Jerusalem

X-WR-TIMEZONE:Asia/Jerusalem
BEGIN:VEVENT

UID:1102@biology.technion.ac.il

DTSTART;TZID=Asia/Jerusalem:20220704T130000

DTEND;TZID=Asia/Jerusalem:20220704T140000

DTSTAMP:20220713T072650Z

URL:https://biology.technion.ac.il/en/seminars/martin-akerman-learn-about-
 great-options-in-the-industry-in-the-interface-between-biology-and-compute
 r-science/

SUMMARY:Martin Akerman-"learn about great options in the industry in the in
 terface between biology and computer science" [No Categories]
DESCRIPTION:Location:   \n Affiliation: \n Host:\n Learn about great option
 s in the industry at the interface of biologyand computer science Martin 
 Akerman is a Technion Alumni who completed his undergraduate and  PhD at 
 the Faculty of Biology. He isthe co-founder and CTO of Envisagenics\, an A
 rtificial Intelligence-drivenbiotechnology company based in New York\, tha
 t focuses onthe discovery of new drug targets for RNA therapeutics and imm
 unotherapies.  Envisagenics’ principal technologyis the SpliceCore® di
 scovery platform\, that applies machine learning algorithmsto RNA-seq data
 \, to uncover new treatments forneurodegeneration and cancer. In his pres
 entation\, Martin will discuss how his company partners withbiopharmaceuti
 cal companies and academic institutions to advance their drugdiscovery cap
 abilities. He will discuss the role that machine learning plays in today
 ’s  biopharmaindustry and Envisagenics’ approach to produce actionabl
 e and  transparent predictions that sparkdrug development collaborations 

END:VEVENT

BEGIN:VTIMEZONE

TZID:Asia/Jerusalem

X-LIC-LOCATION:Asia/Jerusalem

BEGIN:DAYLIGHT

DTSTART:20220325T030000

TZOFFSETFROM:+0200

TZOFFSETTO:+0300

TZNAME:IDT

END:DAYLIGHT

END:VTIMEZONE
END:VCALENDAR